Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2769 Views
-
Last post by NHE
-
- 0 Replies
- 1299 Views
-
Last post by frodo
-
- 0 Replies
- 1341 Views
-
Last post by NHE
-
- 0 Replies
- 1366 Views
-
Last post by frodo
-
- 0 Replies
- 1526 Views
-
Last post by NHE
-
- 0 Replies
- 1242 Views
-
Last post by frodo
-
- 0 Replies
- 1608 Views
-
Last post by NHE
-
- 0 Replies
- 2010 Views
-
Last post by DIM
-
- 0 Replies
- 1847 Views
-
Last post by seeva